sylvant
Generic: siltuximab
Labeler: recordati rare diseases, inc.Drug Facts
Product Profile
Brand Name
sylvant
Generic Name
siltuximab
Labeler
recordati rare diseases, inc.
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Routes
Active Ingredients
siltuximab 400 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
73090-421
Product ID
73090-421_c32bb83e-f9f4-4a6e-928a-f736138996b6
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
BLA
Application Number
BLA125496
Listing Expiration
2026-12-31
Marketing Start
2014-04-23
Pharmacologic Class
Established (EPC)
Mechanism of Action
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
73090421
Hyphenated Format
73090-421
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sylvant (source: ndc)
Generic Name
siltuximab (source: ndc)
Application Number
BLA125496 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 400 mg/1
Packaging
- 1 VIAL, SINGLE-DOSE in 1 BOX (73090-421-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "c32bb83e-f9f4-4a6e-928a-f736138996b6", "openfda": {"nui": ["N0000191006", "N0000191004"], "unii": ["T4H8FMA7IM"], "rxcui": ["1658132", "1658135", "1658139", "1658141"], "spl_set_id": ["8d663642-f52e-49c0-a023-2da083fdfc0b"], "pharm_class_epc": ["Interleukin-6 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-6 Antagonists [MoA]"], "manufacturer_name": ["Recordati Rare Diseases, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 BOX (73090-421-01) / 1 INJECTION, POWDER, FOR SOLUTION in 1 VIAL, SINGLE-DOSE", "package_ndc": "73090-421-01", "marketing_start_date": "20140423"}], "brand_name": "Sylvant", "product_id": "73090-421_c32bb83e-f9f4-4a6e-928a-f736138996b6", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "pharm_class": ["Interleukin-6 Antagonist [EPC]", "Interleukin-6 Antagonists [MoA]"], "product_ndc": "73090-421", "generic_name": "Siltuximab", "labeler_name": "Recordati Rare Diseases, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sylvant", "active_ingredients": [{"name": "SILTUXIMAB", "strength": "400 mg/1"}], "application_number": "BLA125496", "marketing_category": "BLA", "marketing_start_date": "20140423", "listing_expiration_date": "20261231"}